Literature DB >> 8079708

Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution.

P E Keipert1, N S Faithfull, J D Bradley, D Y Hazard, J Hogan, M S Levisetti, R M Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8079708     DOI： 10.1007/978-1-4615-2468-7_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  The Emulsified PFC Oxycyte® Improved Oxygen Content and Lung Injury Score in a Swine Model of Oleic Acid Lung Injury (OALI).

Authors:  Ashraful Haque; Anke H Scultetus; Francoise Arnaud; Leonora J Dickson; Steve Chun; George McNamee; Charles R Auker; Richard M McCarron; Richard T Mahon
Journal:  Lung       Date:  2016-10-04       Impact factor: 2.584

Review 2.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

Review 3.  Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.

Authors:  D R Spahn
Journal:  Crit Care       Date:  1999-09-24       Impact factor: 9.097

4.  The effect of isovolemic hemodilution with oxycyte, a perfluorocarbon emulsion, on cerebral blood flow in rats.

Authors:  Zhong-jin Yang; Chrystal D Price; Gerardo Bosco; Micheal Tucci; Nagwa S El-Badri; Devanand Mangar; Enrico M Camporesi
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

Review 5.  Investigation on artificial blood or substitute blood replace the natural blood.

Authors:  Sh Keyhanian; M Ebrahimifard; M Zandi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.